Business

Isodiol International Inc. Announces Extension of Licensing Agreement with Kathy Ireland and Level Brands

Isodiol International Inc. Announces Extension of Licensing Agreement with Kathy Ireland and Level Brands.

articleIsodiol International IncJanuary 22, 20184/company/isodiol-international-inc/news/isodiol-international-inc-announces-extension-of-licensing-agreement-with-kathy-ireland-and-level-brands
Isodiol International Inc. Announces Extension of Licensing Agreement with Kathy Ireland and Level Brands

About this update from Isodiol International Inc

[{"type":"text","content":"\n\n VANCOUVER, British Columbia, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc., (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has signed an amendment to the license agreement with Level Brands Inc. (NYSE American:LEVB). The amended agreement extends the terms from five years to ten years and expands the territorial coverage from North America to worldwide. The amendment was entered into after both parties concluded discussions contemplated under the terms of the agreement.\n Marcos Agramont, CEO of Isodiol said, “Upon further discussion with Kathy Ireland and the Level Brands team, it became clear that both sides share a common goal, which is to help people around the globe understand how cannabidiol is beneficial for the human body. With this expanded agreement, we will now be able to introduce a variety of Isodiol brands to Kathy’s extremely large network around the globe. Overall, Level Brands is innovative in licensing, marketing and brand management and this will further assist Isodiol in providing consistent and highly bioactive products. The opportunity to increase this partnership from North America to worldwide is something that we believe will have a tremendous impact on Isodiol in the short and long term.” Kathy Ireland, Chairman Emeritus and Chief Brand Strategist of Level Brands said, “Our vision is that Isodiol will become the leading CBD company in the world. The CBD market is at its infancy, and we believe, based on our research and decades of brand building, that the CBD industry will see enormous growth over the next decade on a worldwide basis. We look forward to working with the Isodiol team to execute on a multi-faceted marketing strategy that we feel will enable Isodiol to grow its bulk and private label businesses, as well be able to rapidly go to market with specialized branded lines of unique and best in class products.” The Isodiol product portfolio will include body balms, tinctures, personal care, nano-mist, and functional beverages. Martin Sumichrast, Chairman and CEO of Level Brands also added, “We believe that the technology that the Isodiol team has acquired an...

More updates from Isodiol International Inc